Lembo

Eversource Energy Announces Leadership Changes Effective May 4, 2022

Retrieved on: 
Wednesday, May 4, 2022

Eversource Energy (NYSE: ES) today announced that Phil Lembo is retiring as Chief Financial Officer and as part of the companys leadership succession plan John Moreira, the companys Senior Vice President and Treasurer, has been elected as Chief Financial Officer, effective today.

Key Points: 
  • Eversource Energy (NYSE: ES) today announced that Phil Lembo is retiring as Chief Financial Officer and as part of the companys leadership succession plan John Moreira, the companys Senior Vice President and Treasurer, has been elected as Chief Financial Officer, effective today.
  • As Chief Financial Officer, he will oversee Eversource Energys finance, accounting, investor relations, budgeting, insurance, risk management, supply chain, regulatory, real estate and facilities functions.
  • He will also remain Eversource Energy Treasurer.
  • Eversource transmits and delivers electricity and natural gas and supplies water to approximately 4.4 million customers in Connecticut, Massachusetts and New Hampshire.

Ritter Pharmaceuticals Appoints Esteemed Gastroenterologist Anthony J. Lembo, M.D. to its Medical Advisory Board

Retrieved on: 
Tuesday, August 13, 2019

We are fortunate to have Dr. Lembo, who will be an invaluable resource, join our Medical Advisory Board, said Andrew J. Ritter, CEO of Ritter Pharmaceuticals.

Key Points: 
  • We are fortunate to have Dr. Lembo, who will be an invaluable resource, join our Medical Advisory Board, said Andrew J. Ritter, CEO of Ritter Pharmaceuticals.
  • Dr. Lembo is Director, GI Motility and Functional Bowel Disorder Center at Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School.
  • Dr. Lembo remarked, I am excited to join Ritter Pharmaceuticals Medical Advisory Board at such a crucial time when the top-line data readout from their Phase 3 study of RP-G28 is imminent.
  • Ritter cautions readers not to place undue reliance on any forward-looking statements, which speak only as of the date they were made.